# Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus

> **NCT05934903** · NA · TERMINATED · sponsor: **Yale University** · enrollment: 4 (actual)

## Conditions studied

- Status Epilepticus
- Refractory Status Epilepticus

## Interventions

- **DEVICE:** Transcranial Direct Current Stimulation

## Key facts

- **NCT ID:** NCT05934903
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-08-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Unable to meet adequate enrolment numbers for feasibility.
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05934903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05934903, "Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05934903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*